617MO Safety and tolerability of INCB123667, a selective CDK2 inhibitor, in patients (pts) with advanced solid tumors: A phase I study. - Simonelli, M.; Lorusso, D.; Homicsko, K.; Seguy, F.; Kinder, M.; Liu, Q.; Croft, E.; Kitano, S. (Annals of Oncology, 2024)